» Articles » PMID: 39223621

Repair of Annulus Fibrosus Defects Using Decellularized Annulus Fibrosus Matrix/chitosan Hybrid Hydrogels

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2024 Sep 2
PMID 39223621
Authors
Affiliations
Soon will be listed here.
Abstract

Degenerative disc disease is the leading cause of lower back and leg pain, considerably impacting daily life and incurring substantial medical expenses for those affected. The development of annulus fibrosus tissue engineering offers hope for treating this condition. However, the current annulus fibrosus tissue engineering scaffolds fail to accurately mimic the natural biological environment of the annulus fibrosus, resulting in limited secretion of extracellular matrix produced by the seeded cells and poor biomechanical properties of the constructed biomimetic annulus fibrosus tissue. This inability to match the biomechanical performance of the natural annulus fibrosus hinders the successful treatment of annulus fibrosus defects. In this study, we fabricated decellularized annulus fibrosus matrix (DAFM)/chitosan hydrogel-1 (DAFM: Chitosan 6:2) and DAFM/chitosan hydrogel-2 (DAFM: Chitosan 4:4) by varying the ratio of DAFM to chitosan. Rat annulus fibrosus (AF)-derived stem cells were cultured on these hydrogel scaffolds, and the cell morphology, AF-related gene expression, and Interleukin-6 (IL-6) levels were investigated. Additionally, magnetic resonance imaging, Hematoxylin and eosin staining, and Safranine and Fast Green staining were performed to evaluate the repair effect of the DAFM/chitosan hydrogels in vivo. The gene expression results showed that the expression of Collagen type I (Col-I), Collagen type I (Col-II), and aggrecan by annulus fibrosus stem cells (AFSCs) cultured on the DAFM/chitosan-1 hydrogel was higher compared with the DAFM/chitosan-2 hydrogel. Conversely, the expression of metalloproteinase-9 (MMP-9) and IL-6 was lower on the DAFM/chitosan-1 hydrogel compared with the DAFM/chitosan-2 hydrogel. In vivo, both the DAFM/chitosan-1 and DAFM/chitosan-2 hydrogels could partially repair large defects of the annulus fibrosus in rat tail vertebrae. In conclusion, the DAFM/chitosan-1 hydrogel could be regarded as a candidate scaffold material for the repair of annulus fibrosus defects, offering the potential for improved treatment outcomes.

Citing Articles

Targeting skeletal interoception: a novel mechanistic insight into intervertebral disc degeneration and pain management.

Zhu H, Ren J, Wang X, Qin W, Xie Y J Orthop Surg Res. 2025; 20(1):159.

PMID: 39940003 PMC: 11823264. DOI: 10.1186/s13018-025-05577-7.


Functional Scaffolds for Bone Tissue Regeneration: A Comprehensive Review of Materials, Methods, and Future Directions.

Todd E, Mirsky N, Silva B, Shinde A, Arakelians A, Nayak V J Funct Biomater. 2024; 15(10).

PMID: 39452579 PMC: 11509029. DOI: 10.3390/jfb15100280.

References
1.
Muthu S, Jeyaraman M, Chellamuthu G, Jeyaraman N, Jain R, Khanna M . Does the Intradiscal Injection of Platelet Rich Plasma Have Any Beneficial Role in the Management of Lumbar Disc Disease?. Global Spine J. 2021; 12(3):503-514. PMC: 9121148. DOI: 10.1177/2192568221998367. View

2.
Pan M, Li Q, Li S, Mao H, Meng B, Zhou F . Percutaneous Endoscopic Lumbar Discectomy: Indications and Complications. Pain Physician. 2020; 23(1):49-56. View

3.
Jing Z, Li L, Song J . Percutaneous transforaminal endoscopic discectomy versus microendoscopic discectomy for upper lumbar disc herniation: a retrospective comparative study. Am J Transl Res. 2021; 13(4):3111-3119. PMC: 8129260. View

4.
Long R, Ferguson S, Benneker L, Sakai D, Li Z, Pandit A . Morphological and biomechanical effects of annulus fibrosus injury and repair in an ovine cervical model. JOR Spine. 2020; 3(1):e1074. PMC: 7084058. DOI: 10.1002/jsp2.1074. View

5.
Avcu E, Bastan F, Guney M, Yildiran Avcu Y, Ur Rehman M, Boccaccini A . Biodegradable Polymer Matrix Composites Containing Graphene-Related Materials for Antibacterial Applications: A Critical Review. Acta Biomater. 2022; 151:1-44. DOI: 10.1016/j.actbio.2022.07.048. View